Management of Alcohol Withdrawal Syndrome

Initial Assessment and Setting

The American College of Physicians and other medical societies recommend determining treatment setting based on risk stratification, admitting patients with severe withdrawal complications, concurrent serious physical or psychiatric disorders, or inadequate social support 1, 2
Request psychiatric consultation for evaluation, acute management, and long-term abstinence planning, as recommended by the American Psychiatric Association 1

The American College of Clinical Pharmacology recommends choosing the appropriate benzodiazepine based on patient characteristics, with long-acting benzodiazepines (chlordiazepoxide, diazepam) preferred for most patients due to better seizure and delirium prevention through gradual self-tapering 3
The American Geriatrics Society recommends using intermediate-acting benzodiazepines (lorazepam) in patients with severe AWS, advanced age, recent head trauma, liver failure, respiratory failure, obesity, or other serious medical comorbidities, starting at 6-12 mg/day and tapering following resolution of withdrawal symptoms 1

The National Institute on Alcohol Abuse and Alcoholism recommends thiamine supplementation as mandatory for all patients, with oral thiamine 100-300 mg/day for standard cases, and parenteral thiamine for high-risk patients (malnourished, severe withdrawal) or suspected Wernicke's encephalopathy 1, 2, 3

The American Academy of Neurology recommends not using antipsychotics as stand-alone treatments, but only as adjuncts to benzodiazepines in severe withdrawal delirium unresponsive to adequate benzodiazepine doses 2
The American Heart Association recommends not using anticonvulsants following alcohol withdrawal seizures for prevention of further seizures 2

The Society of Critical Care Medicine recommends frequent vital sign monitoring, especially during first 72 hours when symptoms peak at 3-5 days post-cessation, and assessing for complications 1, 3

The American Medical Association recommends always giving thiamine immediately when suspected Wernicke's encephalopathy, as delays cause irreversible damage, and never exceeding 10-14 days of benzodiazepine use to prevent iatrogenic dependence 3, 4
The American Society of Addiction Medicine recommends using CIWA for severity assessment and treatment monitoring, not diagnosis, and providing small quantities or supervised doses to reduce misuse risk 1, 2